Digital Therapeutics Market - By Product (Software, Hardware), By Application (Preventive, Treatment), By Business Model (Business-to-Consumer [B2C], Business-to-Business [B2B]) and others ... d others Read more
- Healthcare
- Apr 2024
- 194
- PDF, Excel, PPT
Market Definition
Digital therapeutics are software-based interventions that aim to treat, manage, or prevent medical conditions. They utilize digital platforms, like mobile apps or wearables, to deliver evidence-based therapies, often incorporating elements of cognitive behavioral therapy, education, and monitoring.
Market Insights & Analysis: Global Digital Therapeutics Market (2024-30):
The Global Digital Therapeutics Market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30. The market growth has been primarily attributed to the high healthcare costs, which have increased the adoption of digital therapeutic solutions that offer remote & scalable interventions to prevent or manage conditions, thus reducing the need for expensive in-person care.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2019-22 |
| Base Year: 2023 | |
| Forecast Period: 2024-30 | |
| CAGR (2024-2030) | 20% |
| Regions Covered | North America: US, Canada, Mexico |
| Europe: Germany, The UK, France, Spain, Italy, Rest of Europe | |
| Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific | |
| South America: Brazil, Rest of South America | |
| Middle East & Africa: GCC, South Africa, Rest of MEA | |
| Key Companies Profiled | Omada Health Inc., Google (Fitbit Health Solutions), 2Morrow® Inc., Teladoc Health. Inc. (Livongo), ResMed (Propeller Health), Aptar (Voluntis, Inc.), Welldoc, Inc., Canary Health, Noom, Inc., Biofourmis, Click Therapeutics, Better Therapeutics, Cognoa, CogniFit Inc., Virta Health, Others, |
| Unit Denominations | USD Million/Billion |
Further, there has been widespread availability of smartphones across the world and this has successfully propelled the adoption of digital therapeutics across nations. For instance, as per the Global System for Mobile Communications Association (GSMA), in 2023, about 4.3 billion people, which is 54% of the global population, own a smartphone. With that, the commercialization and clinical application of digital therapeutics (DTx) has significantly increased, accelerating the overall Digital Therapeutics Market.
Moreover, the surge in the demand for these digital therapeutics solutions has led to an increment in the number of strategic activities, including acquisitions & mergers by the key companies, to gain a share in the lateral Digital Therapeutics Market. For instance, in 2023, Sidekick Health, a global leader in digital health innovation, announced the strategic acquisition of Aidhere, a leading developer of prescription digital therapeutics (PDT) based in Germany. Hence, these efforts by global companies are anticipated to drive the Digital Therapeutics Market growth in the coming years as well.
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumptions
- Executive Summary
- Global Digital Therapeutics Market Trends & Developments
- Global Digital Therapeutics Market Dynamics
- Drivers
- Challenges
- Global Digital Therapeutics Market Hotspot & Opportunities
- Global Digital Therapeutics Market Startup Ecosystem
- Entrepreneurial Activity
- Year-on-Year Funding Received
- Funding Received by Top Companies
- Key Investors Active in the Market
- Series-wise Funding Received
- Seed Funding
- Angel Investing
- Venture Capitalists (VC) Funding
- Others
- Global Digital Therapeutics Market Regulations & Policy
- Global Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Size & Analysis
- By Product
- Software- Market Size & Forecast 2019-2030, USD Million
- Hardware- Market Size & Forecast 2019-2030, USD Million
- By Application
- Preventive- Market Size & Forecast 2019-2030, USD Million
- Pre-Diabetes- Market Size & Forecast 2019-2030, USD Million
- Obesity- Market Size & Forecast 2019-2030, USD Million
- Smoking Cessation- Market Size & Forecast 2019-2030, USD Million
- Others (Hypertension, Sleep Hygiene, etc.) - Market Size & Forecast 2019-2030, USD Million
- Treatment/Care- Market Size & Forecast 2019-2030, USD Million
- Cardiovascular Diseases (CVDs)- Market Size & Forecast 2019-2030, USD Million
- Central Nervous System Diseases- Market Size & Forecast 2019-2030, USD Million
- Diabetes- Market Size & Forecast 2019-2030, USD Million
- Musculoskeletal Diseases- Market Size & Forecast 2019-2030, USD Million
- Others (Respiratory Diseases, Drug Substance Abuse, etc.) - Market Size & Forecast 2019-2030, USD Million
- Preventive- Market Size & Forecast 2019-2030, USD Million
- By Business Model
- Business-to-Consumer (B2C)- Market Size & Forecast 2019-2030, USD Million
- Business-to-Business (B2B)- Market Size & Forecast 2019-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
- By Competition
- Competition Characteristics
- Market Share of Companies
- By Product
- Market Size & Analysis
- North America Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- By Business Model- Market Size & Forecast 2019-2030, USD Million
- By Country
- The US
- Canada
- Mexico
- The US Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Canada Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Mexico Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- South America Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- By Business Model- Market Size & Forecast 2019-2030, USD Million
- By Country
- Brazil
- Rest of South America
- Brazil Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Europe Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- By Business Model- Market Size & Forecast 2019-2030, USD Million
- By Country
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Germany Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- The UK Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Treatment Modality- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- France Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Spain Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Italy Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- The Middle East & Africa Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- By Business Model- Market Size & Forecast 2019-2030, USD Million
- By Country
- GCC
- South Africa
- Rest of the Middle East & Africa
- GCC Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- South Africa Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Asia-Pacific Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- By Business Model- Market Size & Forecast 2019-2030, USD Million
- By Country
- China
- Japan
- Australia
- South Korea
- India
- Rest of Asia-Pacific
- China Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Japan Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Australia Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- South Korea Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- India Digital Therapeutics Market Outlook, 2019-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product- Market Size & Forecast 2019-2030, USD Million
- By Application- Market Size & Forecast 2019-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Global Digital Therapeutics Market Key Strategic Imperatives for Growth & Success
- Competitive Outlook
- Company Profiles
- Omada Health Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Google (Fitbit Health Solutions)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- 2Morrow® Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Teladoc Health. Inc. (Livongo)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- ResMed (Propellar Health)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Aptar (Voluntis, Inc.)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Welldoc, Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Canary Health
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Noom, Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Biofourmis
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Click Therapeutics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Better Therapeutics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Cognoa
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- CogniFit Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Virta Health
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Omada Health Inc.
- Company Profiles
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making
We’d love to understand what matters most to you.